A model for determining the optimum histology of sentinel lymph nodes in breast cancer

Journal of Clinical Pathology

Volumn 57, Issue 5, 2004, Pages 467-471

  Cserni, G ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; GEOMETRY; HISTOPATHOLOGY; LYMPH NODE METASTASIS; MEASUREMENT; MODEL; PRIORITY JOURNAL; RANDOMIZATION; SENTINEL LYMPH NODE; TISSUE SECTION; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 2442476428     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.014308     Document Type: Article

References (26)

1. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;180:700-4.
2. Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-6.
3. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098-103.
4. Sabel MS, Zhang P, Barnwell JM, et al. Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Oncol 2001;77:243-6.
5. Stitzenberg KB, Calvo BF, Iacocca MV, et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 2002;117:729-37.
6. Cserni G, Amendoeira I, Apostolikas N, et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003;39:1654-67.
7. Sobin LH, Wittekind Ch, eds. UICC TNM classification of malignant tumours, 6th ed. New York: John Wiley and Sons, 2002.
8. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-31.
9. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastoses from breast carcinoma. Reviewing the dilemma. Cancer 1997;80:1188-97.
10. Huvas A, Hutter RVP, Berg J. Significance of macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-6.
11. American Joint Committee on Cancer. Breast. In: Greene FL, Page DL, Fleming ID, eds. AJCC cancer staging handbook, 6th ed. New York: Springer Verlag, 2002:155-81.
12. Schwartz GF, Giuliano AE, Veronesi U, et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33:579-89.
13. Millis RR, Springall R, Lee AHS, et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 2002;86:396-401.
14. Torrenga H, Rohusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-2.
15. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European working group for breast screening pathology. J Clin Pathol [in press.].
16. Cserni G. Sentinel lymph node histopathology in breast cancer [letter]. Am J Surg Pathol 2002;26:1368.
17. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 1998;69:212-18.
18. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999;52:871-3.
19. Weaver DL. Sentinel lymph nodes and breast carcinoma. Am J Surg Pathol 2003;27:842-5.
20. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 2000;113:351-4.
21. Diaz LK, Hunt K, Ames F, et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 2003;27:385-9.
22. Cserni G. Histologic localization of sentinel lymph node metastases in breast cancer [letter]. Am J Surg Pathol 2004;28:275.
23. Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2001;67:86-91.
24. Cserni G. The effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2003;69:419-23.
25. Teng S, Dupont E, McCann C, et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000;66:574-8.
26. Jakub JW, Diaz NM, Ebert MD, et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 2002;184:302-6.